Clinical study to assess the effectiveness of product on human volunteers

Brief Summary: OBJECTIVE: The objective of this study will be to evaluatethe in- vivo efficacy and safety of a breast line firming formulation in termsof improvement in breast firmness, breast shape & breast upliftment onhealthy female subjects.

The evaluation is performed using: Subject Self Evaluation, DermatologicalEvaluation: Cosmetic Acceptability, Expert assessment, Anthropometricmeasurements, Cutometry

POPULATION: 36 Female subjects will be selected for thestudy.

The subjects selected for this study will be healthyfemales, aged between 18-40 years, complaining flaccid breast, withBMI-25-35kg/m2.

STUDY DURATION: 56days following the application of the product.

1)Indian / Asian female subjects 2)Healthy subjects 3) Skin is healthy on the studied anatomic unit 4) Volunteers complaining flaccid breast.
5)Body Mass Index- 25-35 kg/m2.

Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2.
Having refused to give her/his assent by not signing the consent form 3.
Taking part in another study liable to interfere with this study 4.
Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months) 5.
Having a progressive asthma (either under treatment or last fit in the last 2 years) 6.
Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis) 7.
Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 8.
Being epileptic.
Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 10.
Having cutaneous hypersensitivity.
Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.

Recruitment & Eligibility